How can statisticians improve dose decisions and drive innovation in their everyday work?
I speak with Marie-Karelle Rivière and Anaïs Andrillon from Saryga about Project Optimus, their approach to dose optimization, and what it takes to turn challenging questions into meaningful research.
How can statisticians improve dose decisions and drive innovation in their everyday work?
I speak with Marie-Karelle Rivière and Anaïs Andrillon from Saryga about Project Optimus, their approach to dose optimization, and what it takes to turn challenging questions into meaningful research.
How can statisticians improve dose decisions and drive innovation in their everyday work?
I speak with Marie-Karelle Rivière and Anaïs Andrillon from Saryga about Project Optimus, their approach to dose optimization, and what it takes to turn challenging questions into meaningful research.
What does “quality” really mean in statistical programming?
In this episode of The Effective Statistician, I speak with Andrew (Andy) York about the evolving world of programming validation, traceability, and quality assurance in clinical trials. Andy has decades of experience in statistical programming, leadership roles across pharma and CROs, and now works with AI-driven solutions focused on improving validation and traceability.
We discuss why traditional approaches to validation are becoming increasingly difficult to sustain, how expectations from regulators continue to grow, and why traceability is far more than just linking programs and datasets.
Andy also shares how modern AI-powered tools can automatically map programming workflows, connect datasets and outputs, and create end-to-end traceability from raw data to final tables, figures, and listings.
If you work with statistical programming, clinical data workflows, submissions, or validation processes, this episode will challenge some long-held assumptions and introduce you to where the future may be heading.
What does “quality” really mean in statistical programming?
In this episode of The Effective Statistician, I speak with Andrew (Andy) York about the evolving world of programming validation, traceability, and quality assurance in clinical trials. Andy has decades of experience in statistical programming, leadership roles across pharma and CROs, and now works with AI-driven solutions focused on improving validation and traceability.
We discuss why traditional approaches to validation are becoming increasingly difficult to sustain, how expectations from regulators continue to grow, and why traceability is far more than just linking programs and datasets.
Andy also shares how modern AI-powered tools can automatically map programming workflows, connect datasets and outputs, and create end-to-end traceability from raw data to final tables, figures, and listings.
If you work with statistical programming, clinical data workflows, submissions, or validation processes, this episode will challenge some long-held assumptions and introduce you to where the future may be heading.
What does “quality” really mean in statistical programming?
In this episode of The Effective Statistician, I speak with Andrew (Andy) York about the evolving world of programming validation, traceability, and quality assurance in clinical trials. Andy has decades of experience in statistical programming, leadership roles across pharma and CROs, and now works with AI-driven solutions focused on improving validation and traceability.
We discuss why traditional approaches to validation are becoming increasingly difficult to sustain, how expectations from regulators continue to grow, and why traceability is far more than just linking programs and datasets.
Andy also shares how modern AI-powered tools can automatically map programming workflows, connect datasets and outputs, and create end-to-end traceability from raw data to final tables, figures, and listings.
If you work with statistical programming, clinical data workflows, submissions, or validation processes, this episode will challenge some long-held assumptions and introduce you to where the future may be heading.